Terms: = Pancreatic cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Prognosis
46 results:
1. Undifferentiated Carcinoma with Osteoclast-like Giant Cells of the Pancreas: Molecular Genetic Analysis of 13 Cases.
Hrudka J; Kalinová M; Ciprová V; Moravcová J; Dvořák R; Matěj R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542259
[TBL] [Abstract] [Full Text] [Related]
2. Transformation of G1-G2 neuroendocrine tumors to neuroendocrine carcinomas following peptide receptor radionuclide therapy.
Cordero-Hernandez IS; Ross AC; Dasari A; Halperin DM; Chasen B; Yao JC
Endocr Relat Cancer; 2024 Apr; 31(4):. PubMed ID: 38329269
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment.
Ikezawa K; Urabe M; Kai Y; Takada R; Akita H; Nagata S; Ohkawa K
Jpn J Clin Oncol; 2024 Mar; 54(3):271-281. PubMed ID: 38109477
[TBL] [Abstract] [Full Text] [Related]
4. High overall copy number variation burden by genome-wide methylation profiling holds negative prognostic value in surgically treated pancreatic ductal adenocarcinoma.
Detlefsen S; Boldt HB; Burton M; Thomsen MM; Rasmussen LG; Ørbeck SV; Pfeiffer P; Mortensen MB; de Stricker K
Hum Pathol; 2023 Dec; 142():68-80. PubMed ID: 37977512
[TBL] [Abstract] [Full Text] [Related]
5. Reduced expression of phosphorylated ataxia-telangiectasia mutated gene is related to poor prognosis and gemcitabine chemoresistance in pancreatic cancer.
Xun J; Ohtsuka H; Hirose K; Douchi D; Nakayama S; Ishida M; Miura T; Ariake K; Mizuma M; Nakagawa K; Morikawa T; Furukawa T; Unno M
BMC Cancer; 2023 Sep; 23(1):835. PubMed ID: 37674118
[TBL] [Abstract] [Full Text] [Related]
6. STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage.
Guo H; Hu Z; Yang X; Yuan Z; Gao Y; Chen J; Xie L; Chen C; Guo Y; Bai Y
Int Immunopharmacol; 2023 Oct; 123():110709. PubMed ID: 37515849
[TBL] [Abstract] [Full Text] [Related]
7. Molecular and Functional Heterogeneity of Primary pancreatic Neuroendocrine Tumors and Metastases.
Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
[TBL] [Abstract] [Full Text] [Related]
8. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
[TBL] [Abstract] [Full Text] [Related]
9. Preoperative hemoglobin levels, extended resections and the body mass index influence survival after pancreaticoduodenectomy.
Panagiotakis E; Selzer T; Böhm G; Schrem H; Vondran FWR; Qu Z; Ockenga J; Hertenstein B; Winterhalter M; Bektas H
Langenbecks Arch Surg; 2023 Mar; 408(1):124. PubMed ID: 36935457
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic and predictive value of tumoral DNA damage repair protein expression in patients with resected pancreatic cancer.
Ceylan F; Guven DC; Taban H; Aktepe O; Sahin TK; Kilickap S; Turker A; Hamaloglu E; Karakoc D; Isik A; Akyol A; Yalcin S; Dizdar O
Clin Res Hepatol Gastroenterol; 2023 Mar; 47(3):102091. PubMed ID: 36738855
[TBL] [Abstract] [Full Text] [Related]
11. MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells.
Yamana Y; Fujihara S; Kobara H; Oura K; Samukawa E; Chiyo T; Okamura M; Yamana H; Tadokoro T; Fujita K; Morishita A; Iwama H; Masaki T
J Cancer Res Ther; 2022 Dec; 18(Supplement):S305-S312. PubMed ID: 36510981
[TBL] [Abstract] [Full Text] [Related]
12. PD-L1-directed PlGF/VEGF blockade synergizes with chemotherapy by targeting CD141
Kim DK; Jeong J; Lee DS; Hyeon DY; Park GW; Jeon S; Lee KB; Jang JY; Hwang D; Kim HM; Jung K
Nat Commun; 2022 Oct; 13(1):6292. PubMed ID: 36272973
[TBL] [Abstract] [Full Text] [Related]
13. Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis.
Melone V; Salvati A; Palumbo D; Giurato G; Nassa G; Rizzo F; Palo L; Giordano A; Incoronato M; Vitale M; Mian C; Di Biase I; Cristiano S; Narciso V; Cantile M; Di Mauro A; Tatangelo F; Tafuto S; Modica R; Pivonello C; Salvatore M; Colao A; Weisz A; Tarallo R
J Transl Med; 2022 Jul; 20(1):306. PubMed ID: 35794609
[TBL] [Abstract] [Full Text] [Related]
14. Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancer.
Zhang X; Mao T; Zhang B; Xu H; Cui J; Jiao F; Chen D; Wang Y; Hu J; Xia Q; Ge W; Li S; Yue M; Ma J; Yao J; Wang Y; Wang Y; Shentu D; Zhang X; Chen S; Bai Y; Wang Y; Zhang X; Liu Q; Sun Y; Fu D; Liu Y; Xiong L; Wang L
EBioMedicine; 2022 Mar; 77():103897. PubMed ID: 35231699
[TBL] [Abstract] [Full Text] [Related]
15. The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms.
Venizelos A; Elvebakken H; Perren A; Nikolaienko O; Deng W; Lothe IMB; Couvelard A; Hjortland GO; Sundlöv A; Svensson J; Garresori H; Kersten C; Hofsli E; Detlefsen S; Krogh M; Sorbye H; Knappskog S
Endocr Relat Cancer; 2021 Nov; 29(1):1-14. PubMed ID: 34647903
[TBL] [Abstract] [Full Text] [Related]
16. Biomarkers for prognosis in pancreatic neuroendocrine tumors.
Zhu M; Sorenson KR; Liu R; Gould Rothberg BE; Halfdanarson TR
Endocr Relat Cancer; 2021 Oct; 28(12):773-782. PubMed ID: 34582360
[TBL] [Abstract] [Full Text] [Related]
17. Hereditary pancreatic cancer.
Abe K; Kitago M; Kitagawa Y; Hirasawa A
Int J Clin Oncol; 2021 Oct; 26(10):1784-1792. PubMed ID: 34476650
[TBL] [Abstract] [Full Text] [Related]
18. Predictive value of m5C regulatory gene expression in pancreatic adenocarcinoma.
Yu X; Zhang Q; Gao F; Zhang M; Zheng Q; He Y; Guo W
Sci Rep; 2021 Sep; 11(1):17529. PubMed ID: 34471186
[TBL] [Abstract] [Full Text] [Related]
19. DNA damage response and repair in pancreatic cancer development and therapy.
Rahnamay Farnood P; Danesh Pazhooh R; Asemi Z; Yousefi B
DNA Repair (Amst); 2021 Jul; 103():103116. PubMed ID: 33882393
[TBL] [Abstract] [Full Text] [Related]
20. Olaparib Monotherapy for Previously Treated pancreatic cancer With DNA Damage Repair Genetic Alterations Other Than Germline BRCA Variants: Findings From 2 Phase 2 Nonrandomized Clinical Trials.
Javle M; Shacham-Shmueli E; Xiao L; Varadhachary G; Halpern N; Fogelman D; Boursi B; Uruba S; Margalit O; Wolff RA; Golan T
JAMA Oncol; 2021 May; 7(5):693-699. PubMed ID: 33662100
[TBL] [Abstract] [Full Text] [Related]
[Next]
